STAT

Spike in prescribing dexamethasone to Covid-19 patients may do more harm than good

Dexamethasone, a potent steroid medication, is in the news as a possible treatment for people with Covid-19. A June 2020 press release for the UK-based RECOVERY clinical trial announced that ...
ascopubs.org

A phase III randomized, open label, multicenter study comparing isatuximab, pomalidomide, and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients ...

Phase 3 randomized study of daratumumab (DARA) + bortezomib/thalidomide/dexamethasone (D-VTd) vs VTd in transplant-eligible (TE) newly diagnosed multiple myeloma ...
ascopubs.org

An open-label, single arm, phase IIa study of bortezomib, lenalidomide, dexamethasone, and elotuzumab in newly diagnosed multiple myeloma.

Lenalidomide, doxorubicin hydrochloride and dexamethasone versus bortezomib, lenalidomide, and dexamethasone prior to scheduled stem cell transplant in newly diagnosed myeloma. This is an ASCO Meeting ...